Systematic Review on the Efficacy of Multimodal Treatment of Sarcomatosis with Cytoreduction and Intraperitoneal Chemotherapy
Authors:
- 10 August 2010
- journal article
- review article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (1) , 207-213
Abstract
Peritoneal sarcomatosis carries a dismal prognosis with median survival of 12 months and no 5-year survivors. The treatment for sarcomatosis has mostly been chemotherapy and surgery for palliation. Recently, cytoreduction (CRS) and intraperitoneal chemotherapy (IPC) has been tried as an alternative for improving regional control and survival, but the efficacy of this combined treatment is difficult to determine. The objective of this review is to evaluate all available evidence to determine the efficacy of this treatment modality. Searches for studies published in peer-reviewed journals before October 2010 were carried out on 3 databases. The reference lists of all identified articles were reviewed for further relevant studies. Relevant studies were then evaluated by 3 investigators, and the quality of each study was assessed. Studies that met an established criterion were reviewed for clinical effectiveness with a tabulation of all results. Eight prospective and one randomized trial were available representing 240 patients treated with CRS and IPC. The median disease-free survival ranged from 2.3 to 22 months, median survival ranged from 5.5 to 39.6 months, and the 5-year survival ranged from 7% to 65%. The surgical morbidity varied from 9% to 44% and the mortality from 0% to 11%. Based on the available data, this treatment approach is currently not recommended in the treatment of sarcomatosis except in experienced centers, in well-selected patients and as part of an experimental protocol.Keywords
This publication has 35 references indexed in Scilit:
- Peritoneal carcinomatosis from colorectal cancer: HIPEC?Surgical Oncology, 2007
- Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with SarcomatosisAnnals of Surgical Oncology, 2007
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus StatementAnnals of Surgical Oncology, 2006
- A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma PeritoneiAnnals of Surgical Oncology, 2006
- Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal CarcinomaJournal of Clinical Oncology, 2006
- Tumor volume as a prognostic factor for sarcomatosisCancer, 2002
- Salvage surgery for patients with recurrent gastrointestinal sarcomaCancer, 2000
- Intraperitoneal chemotherapy in disseminated abdominal sarcomaAnnals of Surgical Oncology, 1997
- Peritonectomy ProceduresAnnals of Surgery, 1995
- Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factorsCancer, 1989